STOCK TITAN

Cellebrite (NASDAQ: CLBT) officer plans tax-driven share sale

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Cellebrite DI Ltd. (CLBT) received a notice that officer Marcus Jewell intends to sell ordinary shares under Rule 144. The notice covers 31,728 ordinary shares, with an indicated value of $331,240.32, to be sold on 08/21/2026. The shares relate to restricted share units vested under an issuer S-8 registered compensation plan, and the sale is described as a mandatory, non-discretionary sell-to-cover arrangement to satisfy income tax liabilities from vesting of performance share unit awards. The filing also lists smaller sales in the prior three months.

Positive

  • None.

Negative

  • None.
Shares intended to be sold 31,728 shares Ordinary shares of Cellebrite DI Ltd. covered by the Rule 144 notice
Indicated value of intended sale $331,240.32 Value associated with the 31,728 ordinary shares in the notice
Planned sale date 08/21/2026 Date on which the reporting person intends to sell the securities
Past sale on 08/12/2026 411 shares for $6,603.87 Ordinary shares sold by Marcus Jewell during the past three months
Past sale on 05/18/2026 12,658 shares for $161,656.58 Ordinary shares sold by Marcus Jewell during the past three months
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Restricted Share Units financial
"Restricted Share Units Vested Under an Issuer S-8 Registered Plan"
Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.
S-8 Registered Plan regulatory
"Restricted Share Units Vested Under an Issuer S-8 Registered Plan"
sell-to-cover arrangement financial
"pursuant to a mandatory, non-discretionary, sell-to-cover arrangement"
performance share unit awards financial
"upon vesting of performance share unit awards only."

FAQ

What does the Form 144 filing by Marcus Jewell mean for Cellebrite DI Ltd. (CLBT)?

The Form 144 indicates Marcus Jewell plans to sell 31,728 CLBT ordinary shares on 08/21/2026. The sale is tied to tax obligations from vested performance share units and is described as a mandatory, non-discretionary sell-to-cover transaction.

How many Cellebrite (CLBT) shares does Marcus Jewell plan to sell and at what indicated value?

Marcus Jewell plans to sell 31,728 ordinary shares of CLBT with an indicated value of $331,240.32. These shares are related to vested restricted share units under a compensation plan and are being sold specifically to cover income tax liabilities from vesting.

When is the planned Rule 144 sale by Marcus Jewell of CLBT shares expected to occur?

The notice states the planned sale date as 08/21/2026. The filer reports the sale will occur under a mandatory, non-discretionary sell-to-cover arrangement associated with tax liabilities arising upon the vesting of performance share unit awards.

What is the source of the Cellebrite (CLBT) shares being sold by Marcus Jewell?

The shares come from restricted share units vested under an issuer S-8 registered compensation plan. The filing specifies they are tied to performance share unit awards, with the sale intended solely to satisfy income tax liabilities from their vesting.

Has Marcus Jewell sold other CLBT shares in the past three months?

Yes. The filing lists sales of 411 shares for $6,603.87 on 08/12/2026 and 12,658 shares for $161,656.58 on 05/18/2026. These were also ordinary shares of Cellebrite DI Ltd. reported under the three-month look-back.

Is Cellebrite DI Ltd. (CLBT) itself selling shares in this Form 144 filing?

No. The filing describes a planned sale by Marcus Jewell of his ordinary shares of CLBT. It is a personal Rule 144 transaction related to vested equity awards and associated tax liabilities, not a primary share offering by the company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature